XML 64 R47.htm IDEA: XBRL DOCUMENT v3.23.3
BUSINESS COMBINATIONS - Narrative (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
12 Months Ended
Jul. 07, 2022
Apr. 25, 2022
Jan. 27, 2022
Jan. 10, 2022
Dec. 29, 2021
Nov. 05, 2021
Oct. 04, 2021
Sep. 30, 2023
Sep. 30, 2022
BUSINESS COMBINATIONS                  
Consideration in cash               $ 0 $ 297,712
Revenue               572,425 547,656
Consolidated net loss               $ (105,140) (337,018)
Plato BioPharma Inc                  
BUSINESS COMBINATIONS                  
Consideration in cash             $ 10,530    
Business acquisition, equity interest issued or issuable (in shares)             57,587    
Business acquisition, equity interest issued or issuable             $ 1,776    
Debt, principal amount             $ 3,000    
Plato BioPharma Inc | Customer relationships                  
BUSINESS COMBINATIONS                  
Weighted-average estimated useful life               8 years  
Envigo RMS Holding Corp                  
BUSINESS COMBINATIONS                  
Consideration in cash           $ 217,808      
Business acquisition, equity interest issued or issuable (in shares)           8,245,918      
Business acquisition, equity interest issued or issuable           $ 439,590      
Shares issuable upon the exercise of stock option (in shares)           790,620      
Exercisable (in dollars per share)           $ 9,930      
Share price (in dollars per share)           $ 44,800      
Total value of options           $ 35,418      
Value of options excluded from purchase price           18,242      
Vested stock options reflected as purchase consideration           17,176      
Transaction costs                 7,700
Revenue                 346,641
Consolidated net loss           2,222     (196,919)
Unrecognized tax benefit           1,861      
Goodwill deductible for tax purposes           $ 50,428      
Envigo RMS Holding Corp | Customer relationships                  
BUSINESS COMBINATIONS                  
Weighted-average estimated useful life               12 years 6 months  
Envigo RMS Holding Corp | Intellectual property                  
BUSINESS COMBINATIONS                  
Weighted-average estimated useful life               8 years 9 months 18 days  
Robinson Services, Inc.                  
BUSINESS COMBINATIONS                  
Consideration in cash         $ 3,250        
Business acquisition, equity interest issued or issuable (in shares)         70,633        
Business acquisition, equity interest issued or issuable         $ 2,898        
Robinson Services, Inc. | Customer relationships                  
BUSINESS COMBINATIONS                  
Weighted-average estimated useful life               7 years 6 months  
Integrated Laboratory Systems, LLC (ILS)                  
BUSINESS COMBINATIONS                  
Consideration in cash       $ 38,993          
Business acquisition, equity interest issued or issuable (in shares)       429,118          
Business acquisition, equity interest issued or issuable       $ 14,466          
Consolidated net loss                 (1,075)
Escrowed amount       3,800          
Settlement of a preexisting relationship       $ (15)          
Revenue                 16,881
Integrated Laboratory Systems, LLC (ILS) | Customer relationships                  
BUSINESS COMBINATIONS                  
Weighted-average estimated useful life               9 years  
Orient BioResource Center, Inc                  
BUSINESS COMBINATIONS                  
Consideration in cash     $ 26,522            
Business acquisition, equity interest issued or issuable (in shares)     677,339            
Business acquisition, equity interest issued or issuable     $ 18,410            
Weighted-average estimated useful life               10 years 1 month 6 days  
Revenue                 35,726
Consolidated net loss                 $ 5,808
Settlement of a preexisting relationship     1,017            
Liabilities incurred     $ 3,325            
Period for payment of consideration     18 months            
Histion LLC Acquisition                  
BUSINESS COMBINATIONS                  
Consideration in cash   $ 950              
Business acquisition, equity interest issued or issuable (in shares)   17,618              
Business acquisition, equity interest issued or issuable   $ 364              
Debt, principal amount   $ 433              
Protypia, Inc.                  
BUSINESS COMBINATIONS                  
Consideration in cash $ 9,460                
Business acquisition, equity interest issued or issuable (in shares) 74,997                
Business acquisition, equity interest issued or issuable $ 806                
Debt, principal amount $ 600                
Protypia, Inc. | Intellectual property                  
BUSINESS COMBINATIONS                  
Weighted-average estimated useful life               8 years 1 month 6 days